St. Jude has been selling so much pace maker device that they have signed on more hospital new contracts between Baltimore and York area. The earning this quarter is going to be very strong. Back in January 26th when stock was $40.50, analyst upgraded the stock as a good buy. Don't get caught losing when the stock goes up to $45 after the earning.
St. Jude has stopped selling Riata about a year and half ago. The impact by the Riata is no more than 3% for the earning this quarter. Riata is a discontinued product 1.5 year ago, what kind of recall and damage that bears really think St. Jude will be receiving! If you are thinking to make a lot of money shorting St. Jude at this level, you are totally stupid.